Crédit Agricole S.A.
Crédit Agricole S.A. (ACA.PA) Stock Competitors & Peer Comparison
See (ACA.PA) competitors and their performances in Stock Market.
Peer Comparison Table: Banks - Regional Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ACA.PA | €16.60 | -4.10% | 52.1B | 7.90 | €2.18 | +6.39% |
| BNP.PA | €89.23 | -2.50% | 99.7B | 8.80 | €10.29 | +8.15% |
| GLE.PA | €68.44 | -3.80% | 51.8B | 10.44 | €6.80 | +2.39% |
| KBC.BR | €112.85 | -0.53% | 45B | 13.03 | €8.70 | +2.83% |
| XBBDC.MC | €3.30 | -0.60% | 34.9B | 9.17 | €0.36 | +6.22% |
| A5G.IR | €9.80 | +1.93% | 20.6B | 10.45 | €0.93 | +6.03% |
| BIRG.IR | €16.74 | +2.54% | 15.6B | 14.28 | €1.15 | +4.26% |
| BCP.LS | €0.91 | +1.79% | 13.2B | 12.74 | €0.07 | +3.36% |
| VLK.AS | €65.20 | +1.95% | 2.7B | 18.50 | €3.47 | +6.46% |
| PTSB.IR | €2.91 | +0.00% | 1.6B | 22.31 | €0.13 | +0.63% |
Stock Comparison
ACA.PA vs BNP.PA Comparison April 2026
ACA.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACA.PA stands at 52.1B. In comparison, BNP.PA has a market cap of 99.7B. Regarding current trading prices, ACA.PA is priced at €16.60, while BNP.PA trades at €89.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACA.PA currently has a P/E ratio of 7.90, whereas BNP.PA's P/E ratio is 8.80. In terms of profitability, ACA.PA's ROE is +0.10%, compared to BNP.PA's ROE of +0.09%. Regarding short-term risk, ACA.PA is less volatile compared to BNP.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ACA.PA.Check BNP.PA's competition here
ACA.PA vs GLE.PA Comparison April 2026
ACA.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACA.PA stands at 52.1B. In comparison, GLE.PA has a market cap of 51.8B. Regarding current trading prices, ACA.PA is priced at €16.60, while GLE.PA trades at €68.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACA.PA currently has a P/E ratio of 7.90, whereas GLE.PA's P/E ratio is 10.44. In terms of profitability, ACA.PA's ROE is +0.10%, compared to GLE.PA's ROE of +0.10%. Regarding short-term risk, ACA.PA is more volatile compared to GLE.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ACA.PA.Check GLE.PA's competition here
ACA.PA vs KBC.BR Comparison April 2026
ACA.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACA.PA stands at 52.1B. In comparison, KBC.BR has a market cap of 45B. Regarding current trading prices, ACA.PA is priced at €16.60, while KBC.BR trades at €112.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACA.PA currently has a P/E ratio of 7.90, whereas KBC.BR's P/E ratio is 13.03. In terms of profitability, ACA.PA's ROE is +0.10%, compared to KBC.BR's ROE of +0.13%. Regarding short-term risk, ACA.PA is more volatile compared to KBC.BR. This indicates potentially higher risk in terms of short-term price fluctuations for ACA.PA.Check KBC.BR's competition here
ACA.PA vs XBBDC.MC Comparison April 2026
ACA.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACA.PA stands at 52.1B. In comparison, XBBDC.MC has a market cap of 34.9B. Regarding current trading prices, ACA.PA is priced at €16.60, while XBBDC.MC trades at €3.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACA.PA currently has a P/E ratio of 7.90, whereas XBBDC.MC's P/E ratio is 9.17. In terms of profitability, ACA.PA's ROE is +0.10%, compared to XBBDC.MC's ROE of +0.14%. Regarding short-term risk, ACA.PA is more volatile compared to XBBDC.MC. This indicates potentially higher risk in terms of short-term price fluctuations for ACA.PA.Check XBBDC.MC's competition here
ACA.PA vs A5G.IR Comparison April 2026
ACA.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACA.PA stands at 52.1B. In comparison, A5G.IR has a market cap of 20.6B. Regarding current trading prices, ACA.PA is priced at €16.60, while A5G.IR trades at €9.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACA.PA currently has a P/E ratio of 7.90, whereas A5G.IR's P/E ratio is 10.45. In terms of profitability, ACA.PA's ROE is +0.10%, compared to A5G.IR's ROE of +0.15%. Regarding short-term risk, ACA.PA is more volatile compared to A5G.IR. This indicates potentially higher risk in terms of short-term price fluctuations for ACA.PA.Check A5G.IR's competition here
ACA.PA vs BIRG.IR Comparison April 2026
ACA.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACA.PA stands at 52.1B. In comparison, BIRG.IR has a market cap of 15.6B. Regarding current trading prices, ACA.PA is priced at €16.60, while BIRG.IR trades at €16.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACA.PA currently has a P/E ratio of 7.90, whereas BIRG.IR's P/E ratio is 14.28. In terms of profitability, ACA.PA's ROE is +0.10%, compared to BIRG.IR's ROE of +0.10%. Regarding short-term risk, ACA.PA is more volatile compared to BIRG.IR. This indicates potentially higher risk in terms of short-term price fluctuations for ACA.PA.Check BIRG.IR's competition here
ACA.PA vs BCP.LS Comparison April 2026
ACA.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACA.PA stands at 52.1B. In comparison, BCP.LS has a market cap of 13.2B. Regarding current trading prices, ACA.PA is priced at €16.60, while BCP.LS trades at €0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACA.PA currently has a P/E ratio of 7.90, whereas BCP.LS's P/E ratio is 12.74. In terms of profitability, ACA.PA's ROE is +0.10%, compared to BCP.LS's ROE of +0.17%. Regarding short-term risk, ACA.PA is more volatile compared to BCP.LS. This indicates potentially higher risk in terms of short-term price fluctuations for ACA.PA.Check BCP.LS's competition here
ACA.PA vs VLK.AS Comparison April 2026
ACA.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACA.PA stands at 52.1B. In comparison, VLK.AS has a market cap of 2.7B. Regarding current trading prices, ACA.PA is priced at €16.60, while VLK.AS trades at €65.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACA.PA currently has a P/E ratio of 7.90, whereas VLK.AS's P/E ratio is 18.50. In terms of profitability, ACA.PA's ROE is +0.10%, compared to VLK.AS's ROE of +0.12%. Regarding short-term risk, ACA.PA is more volatile compared to VLK.AS. This indicates potentially higher risk in terms of short-term price fluctuations for ACA.PA.Check VLK.AS's competition here
ACA.PA vs PTSB.IR Comparison April 2026
ACA.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACA.PA stands at 52.1B. In comparison, PTSB.IR has a market cap of 1.6B. Regarding current trading prices, ACA.PA is priced at €16.60, while PTSB.IR trades at €2.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACA.PA currently has a P/E ratio of 7.90, whereas PTSB.IR's P/E ratio is 22.31. In terms of profitability, ACA.PA's ROE is +0.10%, compared to PTSB.IR's ROE of +0.05%. Regarding short-term risk, ACA.PA is more volatile compared to PTSB.IR. This indicates potentially higher risk in terms of short-term price fluctuations for ACA.PA.Check PTSB.IR's competition here
ACA.PA vs IL0A.IR Comparison April 2026
ACA.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACA.PA stands at 52.1B. In comparison, IL0A.IR has a market cap of 1.3B. Regarding current trading prices, ACA.PA is priced at €16.60, while IL0A.IR trades at €2.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACA.PA currently has a P/E ratio of 7.90, whereas IL0A.IR's P/E ratio is 5.34. In terms of profitability, ACA.PA's ROE is +0.10%, compared to IL0A.IR's ROE of +0.05%. Regarding short-term risk, ACA.PA is more volatile compared to IL0A.IR. This indicates potentially higher risk in terms of short-term price fluctuations for ACA.PA.Check IL0A.IR's competition here
ACA.PA vs CAF.PA Comparison April 2026
ACA.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACA.PA stands at 52.1B. In comparison, CAF.PA has a market cap of 914.4M. Regarding current trading prices, ACA.PA is priced at €16.60, while CAF.PA trades at €109.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACA.PA currently has a P/E ratio of 7.90, whereas CAF.PA's P/E ratio is 13.44. In terms of profitability, ACA.PA's ROE is +0.10%, compared to CAF.PA's ROE of +0.03%. Regarding short-term risk, ACA.PA is less volatile compared to CAF.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ACA.PA.Check CAF.PA's competition here
ACA.PA vs MLCFM.PA Comparison April 2026
ACA.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACA.PA stands at 52.1B. In comparison, MLCFM.PA has a market cap of 744.9M. Regarding current trading prices, ACA.PA is priced at €16.60, while MLCFM.PA trades at €1,250.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACA.PA currently has a P/E ratio of 7.90, whereas MLCFM.PA's P/E ratio is 14.95. In terms of profitability, ACA.PA's ROE is +0.10%, compared to MLCFM.PA's ROE of +0.12%. Regarding short-term risk, ACA.PA is more volatile compared to MLCFM.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ACA.PA.Check MLCFM.PA's competition here
ACA.PA vs CRBP2.PA Comparison April 2026
ACA.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACA.PA stands at 52.1B. In comparison, CRBP2.PA has a market cap of 459.4M. Regarding current trading prices, ACA.PA is priced at €16.60, while CRBP2.PA trades at €33.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACA.PA currently has a P/E ratio of 7.90, whereas CRBP2.PA's P/E ratio is 7.15. In terms of profitability, ACA.PA's ROE is +0.10%, compared to CRBP2.PA's ROE of +0.04%. Regarding short-term risk, ACA.PA is more volatile compared to CRBP2.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ACA.PA.Check CRBP2.PA's competition here
ACA.PA vs CIV.PA Comparison April 2026
ACA.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACA.PA stands at 52.1B. In comparison, CIV.PA has a market cap of 280M. Regarding current trading prices, ACA.PA is priced at €16.60, while CIV.PA trades at €125.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACA.PA currently has a P/E ratio of 7.90, whereas CIV.PA's P/E ratio is 11.59. In terms of profitability, ACA.PA's ROE is +0.10%, compared to CIV.PA's ROE of +0.02%. Regarding short-term risk, ACA.PA is more volatile compared to CIV.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ACA.PA.Check CIV.PA's competition here
ACA.PA vs CNF.PA Comparison April 2026
ACA.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACA.PA stands at 52.1B. In comparison, CNF.PA has a market cap of 260.5M. Regarding current trading prices, ACA.PA is priced at €16.60, while CNF.PA trades at €16.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACA.PA currently has a P/E ratio of 7.90, whereas CNF.PA's P/E ratio is 4.65. In terms of profitability, ACA.PA's ROE is +0.10%, compared to CNF.PA's ROE of +0.03%. Regarding short-term risk, ACA.PA is more volatile compared to CNF.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ACA.PA.Check CNF.PA's competition here
ACA.PA vs CMO.PA Comparison April 2026
ACA.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACA.PA stands at 52.1B. In comparison, CMO.PA has a market cap of 186.6M. Regarding current trading prices, ACA.PA is priced at €16.60, while CMO.PA trades at €117.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACA.PA currently has a P/E ratio of 7.90, whereas CMO.PA's P/E ratio is 9.13. In terms of profitability, ACA.PA's ROE is +0.10%, compared to CMO.PA's ROE of +0.03%. Regarding short-term risk, ACA.PA is more volatile compared to CMO.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ACA.PA.Check CMO.PA's competition here
ACA.PA vs CRAV.PA Comparison April 2026
ACA.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACA.PA stands at 52.1B. In comparison, CRAV.PA has a market cap of 184.6M. Regarding current trading prices, ACA.PA is priced at €16.60, while CRAV.PA trades at €154.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACA.PA currently has a P/E ratio of 7.90, whereas CRAV.PA's P/E ratio is 13.30. In terms of profitability, ACA.PA's ROE is +0.10%, compared to CRAV.PA's ROE of +0.02%. Regarding short-term risk, ACA.PA is more volatile compared to CRAV.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ACA.PA.Check CRAV.PA's competition here
ACA.PA vs CAT31.PA Comparison April 2026
ACA.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACA.PA stands at 52.1B. In comparison, CAT31.PA has a market cap of 172.1M. Regarding current trading prices, ACA.PA is priced at €16.60, while CAT31.PA trades at €123.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACA.PA currently has a P/E ratio of 7.90, whereas CAT31.PA's P/E ratio is 9.22. In terms of profitability, ACA.PA's ROE is +0.10%, compared to CAT31.PA's ROE of +0.03%. Regarding short-term risk, ACA.PA is less volatile compared to CAT31.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ACA.PA.Check CAT31.PA's competition here
ACA.PA vs CCN.PA Comparison April 2026
ACA.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACA.PA stands at 52.1B. In comparison, CCN.PA has a market cap of 163M. Regarding current trading prices, ACA.PA is priced at €16.60, while CCN.PA trades at €154.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACA.PA currently has a P/E ratio of 7.90, whereas CCN.PA's P/E ratio is 10.96. In terms of profitability, ACA.PA's ROE is +0.10%, compared to CCN.PA's ROE of +0.03%. Regarding short-term risk, ACA.PA is more volatile compared to CCN.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ACA.PA.Check CCN.PA's competition here
ACA.PA vs CRLA.PA Comparison April 2026
ACA.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACA.PA stands at 52.1B. In comparison, CRLA.PA has a market cap of 154.9M. Regarding current trading prices, ACA.PA is priced at €16.60, while CRLA.PA trades at €85.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACA.PA currently has a P/E ratio of 7.90, whereas CRLA.PA's P/E ratio is 9.21. In terms of profitability, ACA.PA's ROE is +0.10%, compared to CRLA.PA's ROE of +0.03%. Regarding short-term risk, ACA.PA is less volatile compared to CRLA.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ACA.PA.Check CRLA.PA's competition here
ACA.PA vs BNB.BR Comparison April 2026
ACA.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACA.PA stands at 52.1B. In comparison, BNB.BR has a market cap of 153.6M. Regarding current trading prices, ACA.PA is priced at €16.60, while BNB.BR trades at €382.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACA.PA currently has a P/E ratio of 7.90, whereas BNB.BR's P/E ratio is -0.04. In terms of profitability, ACA.PA's ROE is +0.10%, compared to BNB.BR's ROE of -0.07%. Regarding short-term risk, ACA.PA is more volatile compared to BNB.BR. This indicates potentially higher risk in terms of short-term price fluctuations for ACA.PA.Check BNB.BR's competition here
ACA.PA vs CRTO.PA Comparison April 2026
ACA.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACA.PA stands at 52.1B. In comparison, CRTO.PA has a market cap of 139.1M. Regarding current trading prices, ACA.PA is priced at €16.60, while CRTO.PA trades at €146.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACA.PA currently has a P/E ratio of 7.90, whereas CRTO.PA's P/E ratio is 12.27. In terms of profitability, ACA.PA's ROE is +0.10%, compared to CRTO.PA's ROE of +0.03%. Regarding short-term risk, ACA.PA is less volatile compared to CRTO.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ACA.PA.Check CRTO.PA's competition here
ACA.PA vs CRSU.PA Comparison April 2026
ACA.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACA.PA stands at 52.1B. In comparison, CRSU.PA has a market cap of 131.4M. Regarding current trading prices, ACA.PA is priced at €16.60, while CRSU.PA trades at €215.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACA.PA currently has a P/E ratio of 7.90, whereas CRSU.PA's P/E ratio is 9.38. In terms of profitability, ACA.PA's ROE is +0.10%, compared to CRSU.PA's ROE of +0.03%. Regarding short-term risk, ACA.PA is more volatile compared to CRSU.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ACA.PA.Check CRSU.PA's competition here
ACA.PA vs CRLO.PA Comparison April 2026
ACA.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACA.PA stands at 52.1B. In comparison, CRLO.PA has a market cap of 103M. Regarding current trading prices, ACA.PA is priced at €16.60, while CRLO.PA trades at €103.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACA.PA currently has a P/E ratio of 7.90, whereas CRLO.PA's P/E ratio is 13.15. In terms of profitability, ACA.PA's ROE is +0.10%, compared to CRLO.PA's ROE of +0.02%. Regarding short-term risk, ACA.PA is more volatile compared to CRLO.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ACA.PA.Check CRLO.PA's competition here
ACA.PA vs CRAP.PA Comparison April 2026
ACA.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACA.PA stands at 52.1B. In comparison, CRAP.PA has a market cap of 97.6M. Regarding current trading prices, ACA.PA is priced at €16.60, while CRAP.PA trades at €146.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACA.PA currently has a P/E ratio of 7.90, whereas CRAP.PA's P/E ratio is 7.92. In terms of profitability, ACA.PA's ROE is +0.10%, compared to CRAP.PA's ROE of +0.04%. Regarding short-term risk, ACA.PA is less volatile compared to CRAP.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ACA.PA.Check CRAP.PA's competition here
ACA.PA vs MLGRC.PA Comparison April 2026
ACA.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACA.PA stands at 52.1B. In comparison, MLGRC.PA has a market cap of 56M. Regarding current trading prices, ACA.PA is priced at €16.60, while MLGRC.PA trades at €23.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACA.PA currently has a P/E ratio of 7.90, whereas MLGRC.PA's P/E ratio is 74.38. In terms of profitability, ACA.PA's ROE is +0.10%, compared to MLGRC.PA's ROE of +0.02%. Regarding short-term risk, ACA.PA is more volatile compared to MLGRC.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ACA.PA.Check MLGRC.PA's competition here
ACA.PA vs KN.PA Comparison April 2026
ACA.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACA.PA stands at 52.1B. In comparison, KN.PA has a market cap of 0. Regarding current trading prices, ACA.PA is priced at €16.60, while KN.PA trades at €4.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACA.PA currently has a P/E ratio of 7.90, whereas KN.PA's P/E ratio is 25.01. In terms of profitability, ACA.PA's ROE is +0.10%, compared to KN.PA's ROE of +0.01%. Regarding short-term risk, ACA.PA is more volatile compared to KN.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ACA.PA.Check KN.PA's competition here
ACA.PA vs DD7E.IR Comparison April 2026
ACA.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACA.PA stands at 52.1B. In comparison, DD7E.IR has a market cap of 0. Regarding current trading prices, ACA.PA is priced at €16.60, while DD7E.IR trades at €23.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACA.PA currently has a P/E ratio of 7.90, whereas DD7E.IR's P/E ratio is N/A. In terms of profitability, ACA.PA's ROE is +0.10%, compared to DD7E.IR's ROE of +0.13%. Regarding short-term risk, ACA.PA is more volatile compared to DD7E.IR. This indicates potentially higher risk in terms of short-term price fluctuations for ACA.PA.Check DD7E.IR's competition here